share_log

Behind the Scenes of Eli Lilly's Latest Options Trends

Behind the Scenes of Eli Lilly's Latest Options Trends

Eli Lilly最新的期权趋势幕后
Benzinga ·  11/29 06:46

Financial giants have made a conspicuous bearish move on Eli Lilly. Our analysis of options history for Eli Lilly (NYSE:LLY) revealed 8 unusual trades.

金融巨头对礼来制药发起了明显的看淡举动。我们对礼来制药 (纽交所: LLY) 的期权历史进行分析,发现了8笔飞凡交易。

Delving into the details, we found 12% of traders were bullish, while 75% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $179,046, and 5 were calls, valued at $247,750.

深入细节,我们发现12%的交易者持看好态度,而75%显示出看淡倾向。在我们发现的所有交易中,有3笔看跌期权,价值179,046美元,5笔看涨期权,价值247,750美元。

Predicted Price Range

预测价格区间

Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $400.0 to $1000.0 for Eli Lilly during the past quarter.

分析这些合约的成交量和未平仓量,似乎大户们在过去一个季度里一直关注着礼来制药的股价区间从400.0美元至1000.0美元。

Volume & Open Interest Trends

成交量和未平仓量趋势

Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Eli Lilly's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Eli Lilly's whale trades within a strike price range from $400.0 to $1000.0 in the last 30 days.

在交易期权时,查看成交量和未平仓量是一个有效的举措。这些数据可以帮助您跟踪给定行权价格的礼来制药期权的流动性和兴趣。下面,我们可以观察过去30天内,对所有礼来制药价格区间从400.0美元至1000.0美元的大宗交易分别进行了看涨和看跌的成交量和未平仓量的发展趋势。

Eli Lilly Option Activity Analysis: Last 30 Days

Eli Lilly期权活动分析:最近30天

bigjpg

Largest Options Trades Observed:

观察到的最大期权交易:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Ask Bid Price Strike Price Total Trade Price Open Interest Volume
LLY CALL TRADE BEARISH 01/15/27 $101.8 $98.0 $98.0 $1000.00 $98.0K 91 10
LLY PUT TRADE BEARISH 12/06/24 $84.05 $77.35 $84.04 $875.00 $75.6K 15 10
LLY PUT TRADE BEARISH 12/19/25 $71.55 $67.0 $71.55 $750.00 $71.5K 320 10
LLY CALL TRADE NEUTRAL 01/17/25 $400.9 $393.6 $397.0 $400.00 $39.7K 371 1
LLY CALL TRADE BEARISH 11/29/24 $41.05 $36.25 $37.75 $755.00 $37.7K 199 10
标的 看跌/看涨 交易类型 情绪 到期日 卖盘 买盘 价格 执行价格 总交易价格 未平仓合约数量 成交量
礼来 看涨 交易 看淡 01/15/27 $101.8 $98.0 $98.0 $1000.00 $98.0K 91 10
礼来 看跌 交易 看淡 12/06/24 $84.05 $77.35 $84.04 $875.00 $75.6K 15 10
礼来 看跌 交易 看淡 12/19/25 $71.55 $67.0 $71.55 $750.00 $71.5千美元 320 10
礼来 看涨 交易 中立 01/17/25 $400.9 $393.6 $397.0 $400.00 $39.7K 371 1
礼来 看涨 交易 看淡 11/29/24 $41.05 $36.25 $37.75 $755.00 $37.7千美元 199 10

About Eli Lilly

关于Eli Lilly

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Eli Lilly是一家专注于神经科学,心脏代谢,癌症和免疫学的药物公司。Lilly的主要产品包括用于治疗癌症的Verzenio;用于心脏代谢的Mounjaro,Zepbound,Jardiance,Trulicity,Humalog和Humulin;以及用于免疫学的Taltz和Olumiant。

Current Position of Eli Lilly

Eli Lilly的当前位置

  • With a volume of 8,286, the price of LLY is up 0.07% at $788.76.
  • RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.
  • Next earnings are expected to be released in 67 days.
  • 拥有8,286的成交量,LLY的价格上涨0.07%,报788.76美元。
  • RSI指标暗示该标的股票目前处于超买和超卖的中立区间。
  • 下一次盈利预计将在67天后发布。

What The Experts Say On Eli Lilly

关于Eli Lilly,专家们的看法是什么?

A total of 4 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $1022.5.

过去30天里,共有4位专业分析师对这支股票发表了看法,并设定了$1022.5的平均目标价。

Unusual Options Activity Detected: Smart Money on the Move

检测到期权异动:智慧资金在行动。

Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access.* Maintaining their stance, an analyst from Barclays continues to hold a Overweight rating for Eli Lilly, targeting a price of $975. * An analyst from B of A Securities persists with their Buy rating on Eli Lilly, maintaining a target price of $1100. * An analyst from Wolfe Research has revised its rating downward to Outperform, adjusting the price target to $1000. * An analyst from Deutsche Bank has decided to maintain their Buy rating on Eli Lilly, which currently sits at a price target of $1015.

Benzinga Edge的飞凡期权板块会提前发现潜在的市场变动。看看大资金在你喜爱的股票上的持仓。点击这里查看。* 巴克莱银行的一位分析师继续持有对Eli Lilly的超配评级,目标价为$975。* B of A证券的一位分析师坚持对Eli Lilly的买入评级,维持目标价为$1100。* Wolfe Research的一位分析师将评级下调为跑赢大盘,并将价格目标调整为$1000。* 德意志银行的一位分析师决定继续维持对Eli Lilly的买入评级,目标价目前为$1015。

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.

期权与仅交易股票相比是一种更具风险的资产,但它们具有更高的利润潜力。认真的期权交易者通过每日学习,进出交易,跟随多个指标并密切关注市场来管理这种风险。

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发